


Healthcare Industry NewsFeed
HSMN NewsFeed - 21 Mar 2017
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
HSMN NewsFeed - 21 Mar 2017
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER
HSMN NewsFeed - 20 Mar 2017
Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
HSMN NewsFeed - 17 Mar 2017
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed(R) Products
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed(R) Products
HSMN NewsFeed - 17 Mar 2017
Toshiba Medical’s New Premium Cardiovascular Ultrasound Receives FDA Clearance
Toshiba Medical’s New Premium Cardiovascular Ultrasound Receives FDA Clearance
HSMN NewsFeed - 16 Mar 2017
Sonoma Pharmaceuticals Announces Results from SebuDerm(TM) Gel Study in Treatment of Seborrheic Dermatitis
Sonoma Pharmaceuticals Announces Results from SebuDerm(TM) Gel Study in Treatment of Seborrheic Dermatitis
HSMN NewsFeed - 15 Mar 2017
Bausch & Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
Bausch & Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
HSMN NewsFeed - 15 Mar 2017
OmniGuide Surgical Announces Commercial Launch of VELOCITY(TM) High Performance CO2 Laser Fiber
OmniGuide Surgical Announces Commercial Launch of VELOCITY(TM) High Performance CO2 Laser Fiber
HSMN NewsFeed - 14 Mar 2017
Avelas Biosciences Appoints Alexey Vinogradov, Ph.D., to Board of Directors
Avelas Biosciences Appoints Alexey Vinogradov, Ph.D., to Board of Directors
HSMN NewsFeed - 14 Mar 2017
Teleflex (TFX) Announces 510(k) Clearance and Global Launch of Twin-Pass(R) Torque Dual Access Catheter
Teleflex (TFX) Announces 510(k) Clearance and Global Launch of Twin-Pass(R) Torque Dual Access Catheter
HSMN NewsFeed - 14 Mar 2017
Teleflex (TFX) Announces 510(k) Clearance and U.S. Launch of Spectre(TM) Guidewire
Teleflex (TFX) Announces 510(k) Clearance and U.S. Launch of Spectre(TM) Guidewire
HSMN NewsFeed - 14 Mar 2017
BONESUPPORT(TM) Extends U.S. Distribution Agreement for CERAMENT(TM)|BONE VOID FILLER
BONESUPPORT(TM) Extends U.S. Distribution Agreement for CERAMENT(TM)|BONE VOID FILLER
HSMN NewsFeed - 13 Mar 2017
Spineology(R) Announces Expanded FDA Clearance of Elite(TM) Expandable Interbody Fusion System
Spineology(R) Announces Expanded FDA Clearance of Elite(TM) Expandable Interbody Fusion System
HSMN NewsFeed - 13 Mar 2017
OrthoGrid Systems, Inc. Announces Mark J. Carrico as Director of Marketing
OrthoGrid Systems, Inc. Announces Mark J. Carrico as Director of Marketing
HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
HSMN NewsFeed - 13 Mar 2017
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
HSMN NewsFeed - 13 Mar 2017
Myriad Genetics Launches the EndoPredict(R) Test in the United States for Patients with Breast Cancer
Myriad Genetics Launches the EndoPredict(R) Test in the United States for Patients with Breast Cancer
HSMN NewsFeed - 8 Mar 2017
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
AzurRx Announces Addition of Charles J Casamento to the Board of Directors
HSMN NewsFeed - 8 Mar 2017
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine(R) Foam
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine(R) Foam
HSMN NewsFeed - 8 Mar 2017
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 8 Mar 2017
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
